HFA Premium Access

Planning a new trial – What endpoints?

Event: Heart Failure 2018 & World Congress on Acute Heart Failure
Topic: Acute Heart Failure, Other
Session type: Symposium
Date: 28 May 2018
Time: 08:30 - 10:00

Congress Session

4 presentations in this session

What mortality/morbidity endpoint?

Speaker: Professor K. Swedberg (Gothenburg, SE)

What test of functional capacity?

Speaker: Professor P. Jhund (Glasgow, GB)

What patient reported outcome?

Speaker: Professor G. Filippatos (Athens, GR)

What biomarkers?

Speaker: Professor A. Voors (Groningen, NL)

4 speakers from this session

Professor Karl Swedberg

University of Gothenburg, Gothenburg (Sweden)
5 presentations
0 follower

Professor Pardeep Jhund

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
4 presentations
0 follower

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)
55 presentations
1 follower

Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))
52 presentations
0 follower

This platform is supported by

logo Novo Nordisk